Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Non-Current Deffered Revenue (2024)

Rallybio (RLYB) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $212000.0 as the latest value for Q4 2024.

  • Quarterly Non-Current Deffered Revenue changed N/A to $212000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $212000.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $212000.0 for FY2024, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $212000.0 in Q4 2024 for Rallybio, up from $195000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $212000.0 in Q4 2024 to a low of $195000.0 in Q2 2024.